Drug name - Lumakras
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US10519146 | AMGEN INC | KRAS G12C inhibitors and methods of using the same |
May, 2038
(15 years from now) | |
| US11236091 | AMGEN INC | Solid state forms |
May, 2040
(17 years from now) | |
| EP3630761B1 | AMGEN INC | Kras G12C Inhibitors And Methods Of Using The Same |
May, 2038
(15 years from now) | |
| EP3630761A1 | AMGEN INC | Kras G12C Inhibitors And Methods Of Using The Same |
May, 2038
(15 years from now) | |
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 120MG | TABLET;ORAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.